HK Inno N (XKRX:195940) Construction In Progress : ₩0 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is HK Inno N Construction In Progress?

HK Inno N's annual construction in progress increased from Dec. 2021 (₩22,953 Mil) to Dec. 2022 (₩25,906 Mil) and increased from Dec. 2022 (₩25,906 Mil) to Dec. 2023 (₩48,951 Mil).

HK Inno N Construction In Progress Historical Data

The historical data trend for HK Inno N's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HK Inno N Construction In Progress Chart

HK Inno N Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

50,480.28

109,062.11

22,952.89

25,906.38

48,950.54

HK Inno N Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Construction In Progress	Get a 7-Day Free Trial															-	48,950.54	-	-	-

HK Inno N Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

HK Inno N Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HK Inno N Corp (XKRX:195940) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

100 Pine Avenue, Eulji-ro, Jung-gu, Seoul, KOR

Website

https://www.inno-n.com

HK Inno N Corp manufactures pharmaceutical products.

HK Inno N Headlines

No Headlines